Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

981
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
981
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.1K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.6K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

901
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
901

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of Ground-Based Particle Emissions from an Airbus A350-900 Operating on Conventional and Sustainable Fuels as Part of the ECLIF3 Campaign.

Environmental science & technology·2026
Same author

Duloxetine and cognitive behavioral therapy with phone-based support for the treatment of chronic musculoskeletal pain: a randomized controlled trial.

Pain·2025
Same author

Physical activity promotion in Spanish adults with spinal cord injury: community guidelines, supporting resources and messaging strategies.

Disability and rehabilitation·2025
Same author

Quality participation of physical activity matters for quality of life and subjective wellbeing in people with disabilities.

Psychology of sport and exercise·2025
Same author

25 years of qualitative research in sport and exercise Psychology: How did it Go? and what now?

Psychology of sport and exercise·2025
Same author

Geno4ME Study: implementation of whole genome sequencing for population screening in a large healthcare system.

NPJ genomic medicine·2025
Same journal

A Multicenter Randomized Pragmatic Trial Comparing Intra-Articular Injection, Genicular Nerve Block, and Radiofrequency Ablation for Knee Osteoarthritis Pain: SKOAP Phase 2 Protocol.

Pain medicine (Malden, Mass.)·2026
Same journal

Impact of Adjunctive Truncal Regional Analgesia on Postoperative Sleep Quality After Total Abdominal Hysterectomy: A Prospective Observational Study.

Pain medicine (Malden, Mass.)·2026
Same journal

Considerations for Cervical Medial Branch Nerve Radiofrequency at Spinal Motion Segments Adjacent to Cervical Fusion Constructs: A Technical Note.

Pain medicine (Malden, Mass.)·2026
Same journal

Return to work after neurostimulation for chronic pain: a systematic review and meta-analysis.

Pain medicine (Malden, Mass.)·2026
Same journal

AAPM Consensus Guidelines on Neuromodulation Technologies and Neurocomputer Interfaces for Pain Management and Functional Recovery.

Pain medicine (Malden, Mass.)·2026
Same journal

Painfully different numbers: Spinal patients' self-reported pain ratings in clinical versus research assessments.

Pain medicine (Malden, Mass.)·2026
See all related articles

Related Experiment Video

Updated: Apr 11, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.4K

Metformin: Potential analgesic?

Brett Smith1, Dennis Ang1

  • 1Section on Rheumatology and Immunology, Wake Forest University School of Medicine, Medical Center Blvd, 3rd Floor, Watlington Hall, Winston Salem, North Carolina, USA.

Pain Medicine (Malden, Mass.)
|June 3, 2015
PubMed
Summary
This summary is machine-generated.

Metformin use in patients with diabetes was not associated with lower pain scores, even in those with neuropathic pain. Future research should explore higher metformin doses as a potential pain reliever.

Keywords:
Diabetic NeuropathyNeuropathic PainNeuropathyPain ManagementPain Medicine

More Related Videos

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.4K
Fixation and Operational Method for Abdominal Massage in T2DM Mice
05:57

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

866

Related Experiment Videos

Last Updated: Apr 11, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.4K
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.4K
Fixation and Operational Method for Abdominal Massage in T2DM Mice
05:57

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

866

Area of Science:

  • Endocrinology
  • Pain Management
  • Pharmacology

Background:

  • Diabetes mellitus is a common condition associated with various complications.
  • Pain, particularly neuropathic pain, is a frequent complaint among diabetic patients.
  • Metformin is a widely used first-line medication for type 2 diabetes.

Purpose of the Study:

  • To investigate the association between self-reported metformin use and pain intensity in patients with diabetes.
  • To explore whether metformin has a role in pain management for diabetic individuals.

Main Methods:

  • A cross-sectional survey study was conducted with 329 participants diagnosed with diabetes.
  • Data on pain intensity, neuropathic pain screening, and depression were collected using validated questionnaires.
  • Participants were categorized into metformin users and non-users for comparative analysis.

Main Results:

  • Metformin users (n=162) reported lower depression scores and fewer comorbidities compared to non-users (n=167).
  • Despite these differences, no significant association was found between metformin use and overall pain intensity.
  • Subgroup analysis of patients with neuropathic pain also revealed no significant difference in pain scores between metformin users and non-users.

Conclusions:

  • In this clinic sample, metformin use was not linked to reduced pain intensity in patients with diabetes.
  • Animal studies suggest potential anti-nociceptive properties of metformin.
  • Further research is warranted to evaluate higher doses of metformin as a potential analgesic for pain management in diabetes.